Randy B. Miller, MD shares insights on the history and current state of regenerative medicine, regulatory changes and the influence of technologies like PRP and adipose tissue in an interview with SmartTRAK.
In an interview with SmartTRAK, Randy B. Miller, MD, founder of the American College of Regenerative Medicine, clinical professor in the Division of Plastic Surgery at the University of Miami, and member of the Physician’s Council for the American Association of Tissue Banks, shares his insights on the history and current state of regenerative medicine across various practice areas, focusing on the effects of regulatory changes and the influence of technologies like platelet-rich plasma (PRP) and adipose tissue.
To find out more, click on the following video (26:33 min). Interview topics by timecode and a link to download the complete transcript of the interview are provided below.
Interview Outline by Timecode:
00:16 The early stages of regenerative medicine using adipose tissue and translating experience across different fields of medicine.
02:58 The evolution of the design of adipose recovery cannulas based on application and indication.
07:42 Overview of the 21st Century Cures Act, The Right to Try Act, and the new Florida bill, which impacts regenerative medicine.
17:34 Recent changes in how we think about the ideal form of PRP.
21:20 Other components in plasma that may have a role in improving PRP.
22:40 Combining the benefits of nanofat and PRP in practice.
24:16 Use of PRP and adipose in combination to resolve scars and how these results match internal fibrosis resolution in COVID cases.
Discover the latest insights into the evolution of Regenerative Medicine. Click the button to get the full transcript of our exclusive interview with Dr. Randy B. Miller, founder of the American College of Regenerative Medicine conducted by David Shepard, SmartTRAK GM/Sr Analyst, Orthobio & Regen.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s proprietary methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
